Drugplain

Anubis Barcelona Protective Line .00025 g/50mL

Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene · CREAM · ANUBIS COSMETICS SL

No Recall History
Plain English

Anubis Barcelona Protective Line is a cream containing ethylhexyl methoxycinnamate, butyl methoxydibenzoylmethane, ethylhexyl salicylate, octocrylene at .00025 g/50mL, taken topical. Manufactured by ANUBIS COSMETICS SL.

Key Facts

Brand Name
Anubis Barcelona Protective Line
Generic Name
Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene
NDC Code (Product)
83021-686
Manufacturer
ANUBIS COSMETICS SL
Strength
.00025 g/50mL
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
M020
Drug Class
Vitamin C [EPC]; Non-Standardized Chemical Allergen [EPC]
Marketing Start
11/02/2022

Recall History

No Recall History

Frequently Asked Questions

What is Anubis Barcelona Protective Line used for?

Anubis Barcelona Protective Line contains Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene. It is a cream taken topical. Consult your doctor for specific uses.

Is Anubis Barcelona Protective Line a controlled substance?

Anubis Barcelona Protective Line is not classified as a controlled substance by the DEA.

What is the generic name for Anubis Barcelona Protective Line?

The generic name for Anubis Barcelona Protective Line is Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene. There are no other listed brand versions of Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene.

What is the NDC code for Anubis Barcelona Protective Line .00025 g/50mL?

The NDC (National Drug Code) for Anubis Barcelona Protective Line .00025 g/50mL is 83021-686, listed by ANUBIS COSMETICS SL.

Product NDC

83021-686

Package NDC

83021-686-50

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)